Makito Kaneda
- Co-authors
- Hitoshi KawasujiYoshihiro YamamotoAkitoshi UenoYuki MiyajimaYoshitomo MorinagaYasutaka FukuiIppei SakamakiHideki Tani
- Topics
- COVID-19 Clinical Research Studies (14 papers)SARS-CoV-2 and COVID-19 Research (12 papers)Long-Term Effects of COVID-19 (10 papers)
- Partner nations
- Japan
In The Last Decade
Makito Kaneda
17 papers receiving 219 citations
Peers
Comparison fields: 5 of 60
- Infectious Diseases 190
- Neurology 47
- Epidemiology 38
- Molecular Biology 24
- Modeling and Simulation 23
Countries citing papers authored by Makito Kaneda
This map shows the geographic impact of Makito Kaneda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makito Kaneda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makito Kaneda more than expected).
Fields of papers citing papers by Makito Kaneda
This network shows the impact of papers produced by Makito Kaneda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makito Kaneda. The network helps show where Makito Kaneda may publish in the future.
Co-authorship network of co-authors of Makito Kaneda
This figure shows the co-authorship network connecting the top 25 collaborators of Makito Kaneda. A scholar is included among the top collaborators of Makito Kaneda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makito Kaneda. Makito Kaneda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 12 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | 5 | |
| 12 | 24 | |
| 13 | 14 | |
| 14 | 6 | |
| 15 | 4 | |
| 16 | 8 | |
| 17 | 1 | |
| 18 | 29 | |
| 19 | 7 | |
| 20 | 93 |
About Makito Kaneda
Makito Kaneda is a scholar working on Infectious Diseases, Neurology and Clinical Biochemistry, having authored 21 papers that have together received 221 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (14 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and Long-Term Effects of COVID-19 (10 papers). The work is most often cited by research in Infectious Diseases (190 citations), Modeling and Simulation (23 citations) and Neurology (47 citations). Makito Kaneda has collaborated with scholars based in Japan. Frequent co-authors include Hitoshi Kawasuji, Yoshihiro Yamamoto, Akitoshi Ueno, Yuki Miyajima, Yoshitomo Morinaga, Yasutaka Fukui, Ippei Sakamaki, Hideki Tani, Hiroshi Yamada and Yoshihiro Yoshida. Their work appears in journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.